当前位置: 首页 > 期刊 > 《医学信息》 > 2018年第1期
编号:13203516
踝关节大骨节病的相关研究进展(4)
http://www.100md.com 2018年1月8日 医学信息 2018年第1期
     [19]Yang H J,Zhang Y,Wang Z L,et al.Increased Chondrocyte Apoptosis in Kashin-Beck Disease and Rats Induced by T-2 Toxin and Selenium Deficiency[J].生物醫学与环境科学,2017, 30(5):351-362.

    [20]何颖,陈静宏,张丹,等.T-2毒素和硒对软骨不同分化层细胞增殖的影响[J].中华地方病学杂志, 2016,35(7):477-482.

    [21]李锦,王加丽,罗明秀,等.NIV毒素对软骨细胞骨架蛋白的影响及硒的拮抗作用[J].国外医学医学地理分册,2013,34(3):146-150.

    [22]曹楠.壤塘县大骨节病区地质环境特征分析[D].成都理工大学,2011.

, 百拇医药     [23]刘军蔚,康鹏德,裴福兴. 黄腐酸与大骨节病关系的研究进展[J].中国矫形外科杂志,2011,19(5):398-401.

    [24]Iwasa K,Kanzaki N,Fujishiro T,et al.Arthroscopic ankle arthrodesis for treating osteoarthritis in a patient with kashin-beck disease[J].Case Reports in Medicine,2014,2014:931278.

    [25]郭雄.关注大骨节病软骨损伤的早期生物学标志[J].中华地方病学杂志,2014,33(4):355-356.

    [26]Yang Z,Xu Y,Luo H,et al.Whole-Exome Sequencing for the Identification of Susceptibility Genes of Kashin-Beck Disease[J].Plos One,2014,9(4):e92298.
, 百拇医药
    [27]Zhang F,Guo X,Zhang Y,et al.Genome-wide copy number variation study and gene expression analysis identify ABI3BP as a susceptibility gene for Kashin-Beck disease[J].Human Genetics, 2014,133(6):793-799.

    [28]王伟卓,程一钊,郭雄,等.大骨节病差异表达基因PAPSS2对成骨细胞矿化及碱性磷酸酶活性的影响[J].西安交通大学学报(医学版),2014,35(2):175-181.

    [29]Shi X,Zhang F,Lv A,et al.COL9A1 gene polymorphism is associated with Kashin-Beck disease in a northwest Chinese Han population[J].Plos One,2015,10(3):e0120365.
, http://www.100md.com
    [30]Wang S,Guo X,Wu X M,et al.Genome-Wide Gene Expression Analysis Suggests an Important Role of Suppressed Immunity in Pathogenesis of Kashin-Beck Disease[J].Plos One,2012,7(1):e28439.

    [31]Tang X,Zhou Z K,Liu G,et al.The long-term efficacy and tolerability of hyaluronic acid in adult patients with Kashin-Beck disease of the knee[J].Clinical Rheumatology,2015,34(1):151-156.

    [32]Wen Y,Guo X,Hao J,et al.Integrative analysis of genome-wide association studies and gene expression profiles identified candidate genes for osteoporosis in Kashin-Beck disease patients[J].Osteoporosis International,2016,27(3):1041-1046.
, 百拇医药
    [33]Tang X,Zhou Z,Shen B,et al.Serum levels of TNF-α,IL-1β,COMP,and CTX-II in patients with Kashin-Beck disease in Sichuan,China[J].Rheumatology International,2012,32(11):3503.

    [34]Zhou X,Wang Z,Chen J,et al.Increased levels of IL-6,IL-1α,and TNF-βin Kashin-Beck disease and rats induced by T-2 toxin and selenium deficiency.[J].Rheumatology International, 2014,34(7):995-1004.

    [35]Tang X,Zhou ZK,Shen B,et al.Detection of serum levels of interleukin-6 in patientswith Kashin-Beck disease and osteoarthritis in Kashin-Beckdisease prevalent area[J].Chin J Bone Jt Surg,2012(5):429-432., 百拇医药(刘艳君 刘时璋)
上一页1 2 3 4 5下一页